📣 VC round data is live. Check it out!

CME Group Valuation Multiples

Discover revenue and EBITDA valuation multiples for CME Group and similar public comparables like Intercontinental Exchange, HKEX, London Stock Exchange Group, Deutsche Börse and more.

CME Group Overview

About CME Group

Based in Chicago, CME Group operates exchanges giving investors, suppliers, and businesses the ability to trade futures and derivatives based on interest rates, equity indexes, foreign currencies, energy, metals, and commodities. The Chicago Mercantile Exchange was founded in 1898 and in 2002 completed its IPO. Since then, CME Group has consolidated parts of the industry by merging with crosstown rival CBOT Holdings in 2007 before acquiring Nymex Holdings in 2008 and NEX in 2018. In addition, the company has a 27% stake in S&P Dow Jones Indices, making the Chicago Mercantile Exchange the exclusive venue to trade and clear S&P futures contracts. Through CME's acquisition of NEX, it also expanded into cash foreign exchange, fixed-income trading, and collateral optimization.


Founded

2001

HQ

United States

Employees

3.8K

Financials (LTM)

Revenue: $7B
EBITDA: $5B

EV

$106B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

CME Group Financials

CME Group reported last 12-month revenue of $7B and EBITDA of $5B.

In the same LTM period, CME Group generated $5B in EBITDA and $4B in net income.

Revenue (LTM)


CME Group P&L

In the most recent fiscal year, CME Group reported revenue of $7B and EBITDA of $6B.

CME Group is profitable as of last fiscal year, with gross margin of 86%, EBITDA margin of 89%, and net margin of 62%.

See analyst estimates for CME Group
LTMLast FY202320242025202620272028
Revenue$7B$7B$6B$6B$7B
Gross Profit—$6B$5B$5B$6B
Gross Margin—86%85%86%86%
EBITDA$5B$6B$5B$5B$6B
EBITDA Margin72%89%84%82%89%
EBIT Margin69%69%62%64%65%
Net Profit$4B$4B$3B$4B$4B
Net Margin62%62%58%58%62%

Financial data powered by Morningstar, Inc.

CME Group Stock Performance

CME Group has current market cap of $105B, and enterprise value of $106B.

Market Cap Evolution


CME Group's stock price is $291.23.

CME Group share price increased by 1.2% in the last 30 days, and by 0.8% in the last year.

CME Group has an EPS (earnings per share) of $11.27.

See more trading valuation data for CME Group
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$106B$105B0.7%1.2%-8.8%0.8%$11.27

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

CME Group Valuation Multiples

CME Group trades at 15.8x EV/Revenue multiple, and 22.1x EV/EBITDA.

See NTM and 2027E valuation multiples for CME Group

EV / Revenue (LTM)


CME Group Financial Valuation Multiples

As of May 23, 2026, CME Group has market cap of $105B and EV of $106B.

CME Group has a P/E ratio of 25.1x.

LTMLast FY202320242025202620272028
EV/Revenue15.8x16.3x19.0x17.3x16.3x
EV/EBITDA22.1x18.2x22.7x21.1x18.2x
EV/EBIT22.8x23.6x30.9x27.0x25.1x
EV/Gross Profit—18.9x22.3x20.1x18.9x
P/E25.1x25.8x32.6x29.8x25.8x
EV/FCF24.9x21.4x31.4x29.5x25.3x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified CME Group Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

CME Group Margins & Growth Rates

CME Group grew revenue by 8% but EBITDA decreased by 13% in the last fiscal year.

In the most recent fiscal year, CME Group reported gross margin of 86%, EBITDA margin of 89%, and net margin of 62%.

See estimated margins and future growth rates for CME Group

CME Group Margins

Last FY202420252026202720282029
Gross Margin86%86%86%—
EBITDA Margin89%82%89%73%
EBIT Margin69%64%65%70%
Net Margin62%58%62%63%
FCF Margin76%59%64%46%

CME Group Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth8%10%6%8%
Gross Profit Growth—11%6%—
EBITDA Growth(13%)8%16%(13%)
EBIT Growth9%14%8%16%
Net Profit Growth9%9%15%9%
FCF Growth(36%)6%17%(24%)

Data powered by FactSet, Inc. and Morningstar, Inc.

CME Group Operational KPIs

CME Group's revenue per employee in the last FY averaged $1.7M, while opex per employee averaged $0.6M for the same period.

CME Group's Rule of 40 is 80% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

CME Group's Rule of X is 92% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for CME Group
LTMLast FY202320242025202620272028
Rule of 4078%80%———
Bessemer Rule of X88%92%———
Revenue per Employee—$1.7M———
Opex per Employee—$0.6M———
G&A Expenses to Revenue—2%3%2%2%
R&D Expenses to Revenue4%4%——4%
Opex to Revenue33%35%24%22%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

CME Group Competitors

CME Group competitors include Intercontinental Exchange, HKEX, London Stock Exchange Group, Deutsche Börse, Nasdaq, Cboe Global Markets, Singapore Exchange and BSE India.

Most CME Group public comparables operate across Stock Exchanges and FinTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Intercontinental Exchange8.2x10.0x15.4x14.9x
HKEX7.2x7.0x7.6x8.9x
London Stock Exchange Group5.8x5.8x11.9x11.5x
Deutsche Börse(20.3x)(23.9x)(41.9x)(40.7x)
Nasdaq7.1x10.7x18.7x18.2x
Cboe Global Markets7.8x14.3x21.1x20.6x

This data is available for Pro users. Sign up to see all CME Group competitors and their valuation data.

Start Free Trial

CME Group M&A Activity

CME Group has acquired 1 company to date.

Last acquisition by CME Group was on March 29th 2018. CME Group acquired NEX Group for $5B (EV/Revenue multiple of ).

See M&A valuation multiples

Latest Acquisitions by CME Group

NEX Group
Description
NEX Group is a technology services company providing electronic trading platforms, lifecycle management, and risk solutions for global financial markets. London-headquartered, NEX supports trade execution, portfolio optimization, and cost reduction. Acquired by CME Group in 2018, its platforms serve institutional clients worldwide.
HQ CountryUnited Kingdom
HQ City
London
Deal Date29 Mar 2018
Valuation$5B
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all CME Group acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About CME Group

When was CME Group founded?CME Group was founded in 2001.
Where is CME Group headquartered?CME Group is headquartered in United States.
How many employees does CME Group have?As of today, CME Group has over 3K employees.
Who is the CEO of CME Group?CME Group's CEO is Terrence A. Duffy.
Is CME Group publicly listed?Yes, CME Group is a public company listed on Nasdaq.
What is the stock symbol of CME Group?CME Group trades under CME ticker.
When did CME Group go public?CME Group went public in 2002.
Who are competitors of CME Group?CME Group main competitors include Intercontinental Exchange, HKEX, London Stock Exchange Group, Deutsche Börse, Nasdaq, Cboe Global Markets, Singapore Exchange, BSE India.
What is the current market cap of CME Group?CME Group's current market cap is $105B.
What is the current revenue of CME Group?CME Group's last 12 months revenue is $7B.
What is the current revenue growth of CME Group?CME Group revenue growth (NTM/LTM) is 6%.
What is the current EV/Revenue multiple of CME Group?Current revenue multiple of CME Group is 15.8x.
Is CME Group profitable?Yes, CME Group is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of CME Group?CME Group's last 12 months EBITDA is $5B.
What is CME Group's EBITDA margin?CME Group's last 12 months EBITDA margin is 72%.
What is the current EV/EBITDA multiple of CME Group?Current EBITDA multiple of CME Group is 22.1x.
What is the current FCF of CME Group?CME Group's last 12 months FCF is $4B.
What is CME Group's FCF margin?CME Group's last 12 months FCF margin is 64%.
What is the current EV/FCF multiple of CME Group?Current FCF multiple of CME Group is 24.9x.
How many companies CME Group has acquired to date?As of May 2026, CME Group has acquired 1 company.
What was the largest acquisition by CME Group?$5B acquisition of NEX Group on 29th March 2018 was the largest M&A CME Group has done to date.
What companies CME Group acquired?CME Group acquired NEX Group.
In how many companies CME Group has invested to date?CME Group hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to CME Group

Lists including CME Group

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial